Screening of 100 women for HPV infection and HPV genotyping

A meta‐analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer

“…A list of included studies is shown in Table 1. The HPV prevalence and genotypes were investigated in 10,081 women with normal cervical cytology, [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] there were 158 women with atypical squamous cells of undetermined significance (ASCUS) or atypia, 27,32,[34][35][36][37] | 4651 neoplasia I (CIN I), 27,32,[34][35][36][37][38][39][40][41][42] 183 women with high-grade squamous intraepithelial lesion (HSIL) or CIN II-III, 32,[35][36][37][38][39][40]43 and 1111 women with invasive cervical cancer (ICC). 19,23,29,32,[35][36]…”

“…A list of included studies is shown in Table 1. The HPV prevalence and genotypes were investigated in 10,081 women with normal cervical cytology, 19–34 there were 158 women with atypical squamous cells of undetermined significance (ASCUS) or atypia, 27,32,34–37 360 women with low‐grade squamous intraepithelial lesion (LSIL) or cervical intraepithelial neoplasia I (CIN I), 27,32,34–42 183 women with high‐grade squamous intraepithelial lesion (HSIL) or CIN II‐III, 32,35–40,43 and 1111 women with invasive cervical cancer (ICC) 19,23,29,32,35–40,44–50 . As indicated in Table 2, the overall HPV prevalence was found to be 9% (CI = 6–14) in women with a normal cervix, 55% (CI = 34–75) in ASCUS (atypia) cases, 58% (CI = 43–73) in women with LSIL (CIN I), 69% (CI = 52–82) in HSIL (CIN II‐III) cases, and 81% (CI = 71–88) among women with ICC (Figures 2–3).…”